Skip to main content
Erschienen in: Journal of General Internal Medicine 7/2011

01.07.2011 | Original Research

Temporal Trends in Presentation for Outpatient HIV Medical Care 2000–2010: Implications for Short-term Mortality

verfasst von: Paula S. Seal, MD, MPH, David A. Jackson, MD, Eric Chamot, PhD, James H. Willig, MD, Christa R. Nevin, MSPH, Jeroan J. Allison, MD, MSc, James L. Raper, DSN, CRNP, JD, Mirjam C. Kempf, PhD, MPH, Joseph E. Schumacher, PhD, Michael S. Saag, MD, Michael J. Mugavero, MD, MHSc

Erschienen in: Journal of General Internal Medicine | Ausgabe 7/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Many newly diagnosed patients present to outpatient care with advanced HIV infection. More timely HIV diagnosis and initiation of care has the potential to improve individual health outcomes and has public health implications.

Objective

To assess temporal trends in late presentation for outpatient HIV medial care as measured by CD4 count <200 cells/mm3 and the implications on short-term (1-year) mortality.

Design

We conducted a cohort study nested in a prospective HIV clinical cohort including patients establishing initial outpatient HIV treatment between 2000–2010. Time series regression analysis evaluated temporal trends in late presentation for care measured by the proportion of patients with a CD4 count <200 cells/mm3 or an opportunistic infection at enrollment, and also evaluated trends in short-term mortality.

Participants

Patients establishing initial outpatient HIV treatment between 2000–2010 at an academic HIV clinic.

Main Measures

The proportion of patients with a CD4 count <200 cells/mm3 or an opportunistic infection at initial presentation and short-term (1-year) mortality following clinic enrollment.

Key Results

Among 1121 patients, 41% had an initial CD4 count <200 cells/mm3, 25% had an opportunistic infection and 2.4% died within 1-year of their initial visit. Time series regression analysis demonstrated significant reductions in late presentation for HIV care and decreases in short-term mortality with temporal improvement preceding updated CDC HIV testing recommendations.

Conclusion

We observed a significant decline in the number of patients presenting for outpatient HIV care with advanced disease, particularly in 2006–2010. A significant trend in improved short-term survival among patients establishing HIV care was also observed, likely related to more timely presentation for outpatient care in more recent years.
Literatur
1.
Zurück zum Zitat Campsmith ML, Rhodes PH, Hall HI, Green TA. Undiagnosed HIV Prevalence Among Adults and Adolescents in the United States at the End of 2006. J Acquir Immune Defic Syndr. 2010;53(5):619–24.PubMed Campsmith ML, Rhodes PH, Hall HI, Green TA. Undiagnosed HIV Prevalence Among Adults and Adolescents in the United States at the End of 2006. J Acquir Immune Defic Syndr. 2010;53(5):619–24.PubMed
2.
Zurück zum Zitat Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300(5):520–9.PubMedCrossRef Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300(5):520–9.PubMedCrossRef
3.
Zurück zum Zitat Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 2004. Atlanta: U.S. Department of Health and Human Services, Center for Disease Control and Prevention. 2005.16:1–46. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 2004. Atlanta: U.S. Department of Health and Human Services, Center for Disease Control and Prevention. 2005.16:1–46.
4.
Zurück zum Zitat Dybul M, Bolan R, Condoluci D, et al. Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings. J Infect Dis. 2002;185(12):1818–21.PubMedCrossRef Dybul M, Bolan R, Condoluci D, et al. Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings. J Infect Dis. 2002;185(12):1818–21.PubMedCrossRef
5.
Zurück zum Zitat Gay CL, Napravnik S, Eron JJ Jr. Advanced immunosuppression at entry to HIV care in the southeastern United States and associated risk factors. AIDS. 2006;20(5):775–8.PubMedCrossRef Gay CL, Napravnik S, Eron JJ Jr. Advanced immunosuppression at entry to HIV care in the southeastern United States and associated risk factors. AIDS. 2006;20(5):775–8.PubMedCrossRef
6.
Zurück zum Zitat Keruly JC, Moore RD. Immune status at presentation to care did not improve among antiretroviral naive persons from 1990 to 2006. Clin Infect Dis. 2007;45(10):1369–74.PubMedCrossRef Keruly JC, Moore RD. Immune status at presentation to care did not improve among antiretroviral naive persons from 1990 to 2006. Clin Infect Dis. 2007;45(10):1369–74.PubMedCrossRef
7.
Zurück zum Zitat Mugavero JM, Castellano C, Edelman D, Hicks C. Late diagnosis of HIV infection: the role of age and sex. Am J Med. 2007;120(4):370–3.PubMedCrossRef Mugavero JM, Castellano C, Edelman D, Hicks C. Late diagnosis of HIV infection: the role of age and sex. Am J Med. 2007;120(4):370–3.PubMedCrossRef
8.
Zurück zum Zitat Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009;23(1):41–9.PubMedCrossRef Ulett KB, Willig JH, Lin HY, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009;23(1):41–9.PubMedCrossRef
9.
Zurück zum Zitat Fleishman JA, Yehia BR, Moore RD, et al. The Economic burden of late entry into medical care for patients with HIV infection. Med Care. 2010;48(12):1071–9.PubMedCrossRef Fleishman JA, Yehia BR, Moore RD, et al. The Economic burden of late entry into medical care for patients with HIV infection. Med Care. 2010;48(12):1071–9.PubMedCrossRef
10.
Zurück zum Zitat Marks G, Crepaz N, Janssen R. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20(10):1447–50.PubMedCrossRef Marks G, Crepaz N, Janssen R. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS. 2006;20(10):1447–50.PubMedCrossRef
11.
Zurück zum Zitat Centers for Disease Control and Prevention. Revised Recommendations for HIV Testing in Adults, Adolescents, and Pregnant Women in Health-Care Settings. MMWR Morb Mortal Wkly Rep. 2006;55(RR14):1–17. Centers for Disease Control and Prevention. Revised Recommendations for HIV Testing in Adults, Adolescents, and Pregnant Women in Health-Care Settings. MMWR Morb Mortal Wkly Rep. 2006;55(RR14):1–17.
12.
Zurück zum Zitat Chen RY, Accortt NA, Westfall AO, et al. Distribution of health care expenditures for HIV-infected patients. Clin Infect Dis. 2006;42(7):1003–10.PubMedCrossRef Chen RY, Accortt NA, Westfall AO, et al. Distribution of health care expenditures for HIV-infected patients. Clin Infect Dis. 2006;42(7):1003–10.PubMedCrossRef
13.
Zurück zum Zitat Mugavero MJ, Lin HY, Allison JJ, et al. Failure to establish HIV care: characterizing the“no show” phenomenon. Clin Infect Dis. 2007;45(1):127–30.PubMedCrossRef Mugavero MJ, Lin HY, Allison JJ, et al. Failure to establish HIV care: characterizing the“no show” phenomenon. Clin Infect Dis. 2007;45(1):127–30.PubMedCrossRef
14.
Zurück zum Zitat Willig JH, Westfall AO, Allison J, et al. Nucleoside reverse-transcriptase inhibitor dosing errors in an outpatient HIVclinic in the electronic medical record era. Clin Infect Dis. 2007;45(5):658–61.PubMedCrossRef Willig JH, Westfall AO, Allison J, et al. Nucleoside reverse-transcriptase inhibitor dosing errors in an outpatient HIVclinic in the electronic medical record era. Clin Infect Dis. 2007;45(5):658–61.PubMedCrossRef
16.
Zurück zum Zitat Harrell FE Jr. Regression modeling strategies with applications to linear models logistic regression, and survival analysis. New York, New York: Springer; 2001:16–26. Harrell FE Jr. Regression modeling strategies with applications to linear models logistic regression, and survival analysis. New York, New York: Springer; 2001:16–26.
17.
Zurück zum Zitat Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology. 1995;6(4):356–65.PubMedCrossRef Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology. 1995;6(4):356–65.PubMedCrossRef
18.
Zurück zum Zitat Carpenter J, Bithell J. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med. 2000;19(9):1141–64.PubMedCrossRef Carpenter J, Bithell J. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med. 2000;19(9):1141–64.PubMedCrossRef
19.
Zurück zum Zitat Wylie R, Marler M, Lin H, et al. Project CONNECT: overcoming barriers to establishing HIV care. In: Program and abstracts of the 4th International Conference on HIV Treatment Adherence. Miami; 5–7 April 2009. Wylie R, Marler M, Lin H, et al. Project CONNECT: overcoming barriers to establishing HIV care. In: Program and abstracts of the 4th International Conference on HIV Treatment Adherence. Miami; 5–7 April 2009.
20.
Zurück zum Zitat Mugavero MJ. Improving engagement in HIV care: what can we do? Top HIV Med. 2008;16:156–61.PubMed Mugavero MJ. Improving engagement in HIV care: what can we do? Top HIV Med. 2008;16:156–61.PubMed
21.
Zurück zum Zitat Centers for Disease Control and Prevention. Expanded HIV Testing and Trends in Diagnoses of HIV Infection—District of Columbia, 2004–2008. MMWR Morb Mortal Wkly Rep. 2010;59(24):737–41. Centers for Disease Control and Prevention. Expanded HIV Testing and Trends in Diagnoses of HIV Infection—District of Columbia, 2004–2008. MMWR Morb Mortal Wkly Rep. 2010;59(24):737–41.
22.
Zurück zum Zitat Sabin CA, Smith CJ, Youle M, et al. Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers. AIDS. 2006;20(1):67–71.PubMedCrossRef Sabin CA, Smith CJ, Youle M, et al. Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers. AIDS. 2006;20(1):67–71.PubMedCrossRef
23.
Zurück zum Zitat Chadborn TR, Delpech VC, Sabin CA, Sinka K, Evans BG. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000–2004). AIDS. 2006;20(18):2371–9.PubMedCrossRef Chadborn TR, Delpech VC, Sabin CA, Sinka K, Evans BG. The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000–2004). AIDS. 2006;20(18):2371–9.PubMedCrossRef
24.
Zurück zum Zitat Lewden C, Rosenthal E, Burty C, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN 19 and Mortavic). J Acquir Immune Defic Syndr. 2008;48(5):590–8.PubMedCrossRef Lewden C, Rosenthal E, Burty C, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN 19 and Mortavic). J Acquir Immune Defic Syndr. 2008;48(5):590–8.PubMedCrossRef
25.
Zurück zum Zitat Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39(4):446–53.PubMedCrossRef Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39(4):446–53.PubMedCrossRef
Metadaten
Titel
Temporal Trends in Presentation for Outpatient HIV Medical Care 2000–2010: Implications for Short-term Mortality
verfasst von
Paula S. Seal, MD, MPH
David A. Jackson, MD
Eric Chamot, PhD
James H. Willig, MD
Christa R. Nevin, MSPH
Jeroan J. Allison, MD, MSc
James L. Raper, DSN, CRNP, JD
Mirjam C. Kempf, PhD, MPH
Joseph E. Schumacher, PhD
Michael S. Saag, MD
Michael J. Mugavero, MD, MHSc
Publikationsdatum
01.07.2011
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 7/2011
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-011-1693-x

Weitere Artikel der Ausgabe 7/2011

Journal of General Internal Medicine 7/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.